Home Tags Generics

Tag: Generics

Turing the Screws on Illegal “Comprehensive Schemes”: The FTC and States’...

By Brendan Coffman, Thu Hoang & Nathan Mendelsohn (Wilson Sonsini Goodrich & Rosati)1   On January 27, 2020, the Federal Trade Commission (“FTC”) and the State...

Pay-For-Delay: Who Does the Generic Industry Lobby Represent?

The generic industry lobby, Association for Accessible Medicines (“AAM”), often represents the public interest. In the pharmaceutical industry, it challenges brand drug...

Rethinking Pharmaceutical Product Reformulations

This piece discusses pharmaceutical product reformulations and product hopping strategies, along with the impact that antitrust scrutiny may have on innovation incentives....

ECJ Ruling on Paroxetine

By James Killick, Marc Israel, Jérémie Jourdan & Aqeel Kadri (White & Case LLP)1 On January 30, 2020 (just sneaking in before Brexit), the European...
Europills

Paroxetine – The EU Court of Justice Rules on Pay-For-Delay Settlements...

Maria José Schmidt-Kessen (Copenhagen Business School)1   Introduction While we are still awaiting the judgments in the pending appeals on pay-for-delay settlements in Lundbeck2 and Servier,3 the...
pharma pils image

European Court of Justice Paroxetine Ruling Provides Guidance on Patent Settlement...

Jan Blockx (University of Antwerp)1 Introduction Twelve years ago, on January 15, 2008, the European Commission used its power to conduct unannounced inspections in a sector...

An Examination of the Proposed Teva-Allergan Merger

By William S. Comanor & Diana L. Moss -  The proposed Teva-Allergan merger joins the largest generic pharmaceutical company in the world, Teva Pharmaceuticals, with an...

JUN-12(2)

With the Supreme Court ruling on Obama Care, much of the business world is focused on healthcare. In honor of that attention, we decided...

Antitrust and Intellectual Property: Recent Developments in the Pharmaceuticals Sector

William Michael, Aidan Synnott, Sep 24, 2009 During his campaign for the Presidency, then-Senator Barack Obama promised that he would direct his administration to reinvigorate...

Supreme Court Rules in Reverse Payment Case

Kevin Noonan, Sep 30, 2013 In June, the Supreme Court ruled 5-3 in favor of the Federal Trade Commission in FTC v. Actavis, Inc. Writing...

News

Antitrust Mix by CPI